https://www.indianpharmapost.com/poly-medicure-posts-q1-fy25-consolidated-pat-at-rs-7403-cr-159022024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/solara-active-pharma-sciences-reports-q1-fy25-consolidated-loss-at-rs-1346-cr-159032024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/biolyst-scientific-announced-as-new-brand-name-to-encompass-ems-and-azer-159042024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-approval-from-cofepris-of-mexico-to-market-bhava-to-treat-various-cancers-159052024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/caplin-steriles-gets-usfda-approval-for-ephedrine-sulfate-injection-usp-159062024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/rpg-life-sciences-posts-q1-fy25-pat-higher-at-rs-2676-cr-159072024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/meitheal-acquires-contepo-from-nabriva-therapeutics-to-expand-specialty-biopharmaceuticals-portfolio-159082024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-announces-positive-topline-results-for-nubeqa-from-phase-iii-trial-in-men-with-mhspc-159092024-07-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/industry-hails-union-budget-2024-25-159102024-07-23T00:00:00+05:30always0.9